Frederick Han, MD
Clinical Cardiac Electrophysiology · San Diego, CANPI 1427255967
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 60.1% of it on its own, with 25 other manufacturers making up the rest.
Across 542 payments — averaging $265.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$87K
- Boston Scientific$27K
- Biosense Webster, Inc.$10K
- Medtronic$6K
- Medical Device Business Services, Inc.$5K
- Biotronik Inc.$4K
- plus $6K from 20 others
Across 45 payments — averaging $5009.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Adagio Medical, Inc.$113K
- Abbott$81K
- Boston Scientific$17K
- Medical Device Business Services, Inc.$13K
- Cardiva Medical, Inc.$1K
What the payments were for
- Consulting fees$74,34152%
- Speaking & faculty fees$34,40324%
- Travel & lodging$9,8077%
- Food & beverage$25,52118%
- Education$310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 283 | $86,646 |
| Boston Scientific | 81 | $26,580 |
| Biosense Webster, Inc. | 26 | $10,188 |
| Medtronic(2 entities) | 43 | $5,843 |
| Medical Device Business Services, Inc. | 5 | $4,963 |
| Biotronik Inc. | 45 | $3,958 |
| Altathera Pharmaceuticals LLC | 4 | $2,108 |
| Atricure, Inc. | 14 | $1,045 |
| ZOLL Respicardia, Inc. | 2 | $556 |
| Acutus Medical, Inc. | 3 | $398 |
| Philips North America LLC | 4 | $369 |
| Cardiva Medical, Inc. | 2 | $242 |
| Merit Medical Systems Inc | 2 | $228 |
| Cardiofocus, Inc. | 4 | $205 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $127 |
| Abiomed | 1 | $124 |
| Kestra Medical Technology Services, Inc. | 2 | $116 |
| Boehringer Ingelheim | 5 | $94 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $82 |
| E.r. Squibb & Sons, L.L.C. | 3 | $55 |
| Adagio Medical, Inc. | 1 | $38 |
| Terumo Medical Corporation | 1 | $37 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $35 |
| Pfizer | 2 | $29 |
| Johnson & Johnson | 1 | $19 |
| Cordis US CORP. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADVISOR$26,901
- GENERAL EP$23,438
- Carto 3 System$14,397
- ENSITE$9,863
- Carto Smarttouch$9,348
- CartoSound$9,348
- Advisor Catheter$7,500
- Carto CFAE$6,348
- Fortify Assura, Ellipse ICD$5,000
- Quadra Allure MP RF CRT Pacemkr$4,950
- Accent Pacemaker$3,720
- EnSite Precision Cardiac Mapping System$3,063
- Ensite Cardiac Mapping System$3,000
- NA$2,327
- VIEWMATE$2,253
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$2,200
- Sotalol Hydrochloride$2,108
- Quadra Assura CRT Defibrillator$1,307
- AVEIR$1,304
- RhythmVIEW Work Stations$1,005
How this compares
$144,103 in reported general payments places this provider in the 85th percentile of 290 clinical cardiac electrophysiology providers in California.
See all clinical cardiac electrophysiology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 226 | $229,797 |
| MultaqDronedarone Hcl | 58 | $79,500 |
| XareltoRivaroxaban | 82 | $76,023 |
| Amiodarone Hcl | 108 | $2,875 |
| Flecainide Acetate | 37 | $2,628 |
| Metoprolol Succinate | 108 | $2,193 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 50 | $1,298 |
| Colchicine | 18 | $640 |
| Losartan Potassium | 58 | $495 |
| SotalolSotalol Hcl | 20 | $314 |
| Atorvastatin Calcium | 35 | $280 |
| Carvedilol | 24 | $256 |
| Hydralazine Hcl | 13 | $161 |
| Amlodipine Besylate | 21 | $146 |
| Metoprolol Tartrate | 37 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $29 | $229,797226 claims |
| Johnson & JohnsonXarelto | $19 | $76,02382 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 290 clinical cardiac electrophysiology providers in California.
Other clinical cardiac electrophysiology in San Diego
- Jonathan HsuSan Diego$1.2M
- Ulrika Birgersdotter-GreenSan Diego$384K
- Charles AthillSan Diego$196K
- Gregory FeldSan Diego$157K
- Farshad Raissi ShabariSan Diego$103K
- Shephal DoshiSanta Monica$2.1M
- Leslie SaxonLos Angeles$1.1M
- Rahul BhardwajLoma Linda$935K
- Nicholas Olsonla Jolla$801K
- Jonathan DukesVentura$775K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.